Several rAAV Vectors Efficiently Cross the Blood–brain Barrier and Transduce Neurons and Astrocytes in the Neonatal Mouse Central Nervous System

Zhang, Hongwei, Yang, Bin, Mu, Xin, Ahmed, Seemin Seher, Su, Qin, He, Ran, Wang, Hongyan, Mueller, Christian +4 more·2011·Molecular Therapy
DOI 10.1038/mt.2011.98

Cited by (291)

Items 201–291 of 291

  1. Mucopolysaccharidosis IIIB confers enhanced neonatal intracranial transduction by AAV8 but not by 5, 9 or rh10
    Janine A. Gilkes, Matthew Doran Bloom, Coy Don Heldermon · 2015 · Gene Therapy
  2. Optimized AAV capsids for basal ganglia diseases show robust potency and distribution
    David E. Leib, Y. H. Chen, Luis Tecedor, Paul T. Ranum, Megan S. Keiser, Brian C. Lewandowski, Ellie M. Carrell, S. Arora, Icnelia Huerta-Ocampo, Dulcie Lai et al. · 2025 · Nature Communications
  3. A new protocol for whole-brain biodistribution analysis of AAVs by tissue clearing, light-sheet microscopy and semi-automated spatial quantification
    Miguel Monteiro Lopes, Jacques Paysan, José Rino, Sara Lopes, Luís Pereira de Almeida, Luísa Cortes, Rui Jorge Nobre · 2022 · Gene Therapy
  4. Emerging Concepts in Vector Development for Glial Gene Therapy: Implications for Leukodystrophies
    Georg von Jonquières, Caroline D. Rae, Gary D. Housley · 2021 · Frontiers in Cellular Neuroscience
  5. Selective Neuronal Uptake and Distribution of AAVrh8, AAV9, and AAVrh10 in Sheep After Intra-Striatal Administration
    Erica Mondo, Richard P. Moser, Guangping Gao, Christian Mueller, Miguel Sena‐Esteves, Ellen Sapp, Edith L. Pfister, D. C. O'Connell, Kendra A. Takle, Kirsten E. Erger et al. · 2018 · Journal of Huntington s Disease
  6. Intrathecal AAVrh10 corrects biochemical and histological hallmarks of mucopolysaccharidosis VII mice and improves behavior and survival
    Gemma Pagès, Lydia Giménez‐Llort, Belén García-Lareu, Lorena Ariza, Marc Navarro, Caty Casas, Miguel Chillón, Assumpció Bosch · 2019 · Human Molecular Genetics
  7. Viral Vector Delivery of DREADDs for CNS Therapy
    Ceri A. Pickering, Nicholas D. Mazarakis · 2021 · Current Gene Therapy
  8. Slow Infusion of Recombinant Adeno-Associated Viruses into the Mouse Cerebrospinal Fluid Space
    Dan Wang, Jia Li, Karen Tran, Daniel Robert Burt, Zhong Li, Guangping Gao · 2018 · Human Gene Therapy Methods
  9. Tissue blood volumes and weights in adult beagle dogs.
    R.G. Cuddihy, Russell P. Hall, CHARLES H. HOBBS, Bruce B. Boecker, Bruce A. Muggenburg · 1972 · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  10. The potential of gene delivery for the treatment of traumatic brain injury
    James Dooley, Jasmine Gabriel Hughes, Edward Needham, Katerina A. Palios, Adrian Liston · 2024 · Journal of Neuroinflammation
  11. Challenges for Gene Therapy of CNS Disorders and Implications for Parkinson's Disease Therapies
    Martin Broadstock, Rafael J. Yáñez‐Muñoz · 2012 · Human Gene Therapy
  12. Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration
    Zheng Chai, Xintao Zhang, Kelly Michelle Rigsbee, Mei Wang, Richard Jude Samulski, Chengwen Li · 2018 · Journal of Controlled Release
  13. In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson’s disease
    Lucie Chansel‐Debordeaux, Mathieu Bourdenx, Sandra Doveró, Virginie Grouthier, Nathalie Dutheil, Agnès Espana, Laurent Groc, Clément Jimenez, Erwan Bézard, Benjamin Dehay · 2017 · Gene Therapy
  14. Considerations for the use of virally delivered genetic tools for in-vivo circuit analysis and behavior in mutant mice: a practical guide to optogenetics
    Dóra Zelena, Kornél Demeter, József Haller, Diána Balázsfi · 2017 · Behavioural Pharmacology
  15. Engineering brain-penetrant PROTACs: Bridging molecular design and CNS delivery
    Xinuo Li, Jinran Li, Yuan Sun, Tingting Yao, Yi Lu, Sai Liu, Haotian Li, Yiting Shi, Long Chen, Yongjun Zhao et al. · 2026 · Advanced Drug Delivery Reviews
  16. Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
    Elham Ahmadi, Mehrdad Ravanshad, Jun Xie, Rajesh Panigrahi, Sandeep Singh Jubbal, Santosh Kumar Guru, Gao Guangping, Mazyar Ziyaeyan, Joyce D. Fingeroth · 2021 · Virology Journal
  17. Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs
    Tiffany W. Leong, Arindam Pal, Qi Cai, Zhenghong Gao, Xiaoqing Li, Leonidas G. Bleris, Heather N. Hayenga, Zhenpeng Qin · 2023 · Journal of Controlled Release
  18. Therapeutic strategy for Fabry disease by intravenous administration of adeno‐associated virus 2 or 9 in α‐galactosidase A‐deficient mice
    Yuka Hayashi, Yoshihide Sehara, Ryota Watano, Kenji Ohba, Yuki Takayanagi, Kazuhiro Muramatsu, Yoshio Sakiyama, Hiroaki Mizukami · 2023 · The Journal of Gene Medicine
  19. Making the White Matter Matters: Progress in Understanding Canavan’s Disease and Therapeutic Interventions Through Eight Decades
    Seemin Seher Ahmed, Guangping Gao · 2014 · JIMD Reports
  20. Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases
    Édina Poletto, Gabriela Pasqualim, Roberto Giugliani, Úrsula da Silveira Matte, Guilherme Baldo · 2019 · Genetics and Molecular Biology
  21. An Atoh1 CRE Knock-In Mouse Labels Motor Neurons Involved in Fine Motor Control
    Osita W. Ogujiofor, Iliodora V. Pop, Felipe Espinosa, Razaq O. Durodoye, Michael L. Viacheslavov, Rachel Jarvis, Mark A. Landy, Gord Fishell, Robert P. Machold, Helen C. Lai · 2021 · eNeuro
  22. Gene Therapy for Rett Syndrome: Prospects and Challenges
    Kamal K.E. Gadalla, Paul D. Ross, Ralph D. Hector, Noha Gamal Bahey, Mark E.S. Bailey, Stuart Cobb · 2015 · Future Neurology
  23. AAV Gene Therapy Strategies for Lysosomal Storage Disorders with Central Nervous System Involvement
    Golebiowski, Diane, Bradbury, Allison M., Kwon, Churl-Su, van der Bom, Imramsjah M. J., Stoica, Lorelei, Johnson, Aime K., Wilson, Diane U., Gray-Edwards, Heather L., Hudson, Judith A., Johnson, Jacob A. et al. · 2015 · Neuromethods
  24. Protein Carrier Adeno-Associated Virus
    Mareike Daniela Hoffmann, Ryan James Sorensen, Ajay Extross, Yungui He, Daniel Schmidt · 2025 · ACS Nano
  25. Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating MPS IIIB: Toxicology, Bio-distribution and Immunological Assessments in Primates
    Darren A. Murrey, Bartholomew J. Naughton, F. Jason Duncan, Aaron S. Meadows, Tierra Ware, Katie Campbell, William G. Bremer, Christopher M. Walker, Laurie Goodchild, Brad N. Bolon et al. · 2014 · Human Gene Therapy Clinical Development
  26. Clinical trials in mitochondrial diseases
    Amel Karaa, Thomas Klopstock · 2023 · Handbook of clinical neurology
  27. Gene Therapy for Canavan's Disease Takes a Step Forward
    Seemin Seher Ahmed, Guangping Gao · 2013 · Molecular Therapy
  28. Present insights into the progress in gene therapy delivery systems for central nervous system diseases
    Zefeng Yang, Xinchi Jiang, Jianqing Gao · 2024 · International Journal of Pharmaceutics
  29. Stem cell and gene therapies for leukodystrophies
    Wenhao Lin, Min Zhang, Sirui Zheng, Qizhou Lian · 2025 · Molecular Therapy — Methods & Clinical Development
  30. Insight into the preparation of biopolymeric nanoparticles with lithium and their cellular uptake studies using PC 12 cells
    Geeva, Shoba Narayan · 2022 · Materials Research Innovations
  31. Gene Therapy Methods and Their Applications in Neurological Disorders
    Mingjie Li, B. Joy Snider · 2018 · Elsevier eBooks
  32. Optimized AAV capsids for diseases of the basal ganglia show robust potency and distribution in adult nonhuman primates
    David E. Leib, YH Chen, Luis Tecedor, Paul T. Ranum, Megan S. Keiser, BC Lewandowski, Ellie M. Carrell, S Arora, Icnelia Huerta-Ocampo, Xing Liu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Ineffective behavioral rescue despite partial brain Dp427 restoration by AAV9-U7-mediated exon 51 skipping in mdx52 mice
    Ophélie Vacca, Amel Saoudi, Mathilde Doisy, Xaysongkhame Phongsavanh, Olivier Le Coz, Cathy Nagy, Julia Kuzniar, Cyrille Vaillend, Aurélie Goyenvalle · 2025 · Molecular Therapy — Nucleic Acids
  34. An automated method for the quantification of transgene expression in motor axons of the peripheral nerve
    Hans E. Anderson, John H. Caldwell, Richard F ff Weir · 2018 · Journal of Neuroscience Methods
  35. Genomics Integrated Systems Transgenesis (GENISYST) for gain-of-function disease modelling in Göttingen Minipigs
    Joachim Maxeiner, Rahul Sharma, Carolin Amrhein, Frederic Gervais, Maria Duda, Jonathan Ward, Lars Friis Mikkelsen, Roy Ph. Forster, Michal Malewicz, Jaya Krishnan · 2021 · Journal of Pharmacological and Toxicological Methods
  36. Transduction of Brain Neurons in Juvenile Chum Salmon (Oncorhynchus keta) with Recombinant Adeno-Associated Hippocampal Virus Injected into the Cerebellum during Long-Term Monitoring
    Evgeniya Vladislavovna Pushchina, Mariya E. Bykova, Ekaterina V. Shamshurina, Varaksin Anatoly Alekseevich · 2022 · International Journal of Molecular Sciences
  37. Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
    Reimann, Regina R., Puzio, Martina, Rosati, Antonella, Emmenegger, Marc, Schneider, Bernard L., Valdés, Pamela, Huang, Danzhi, Caflisch, Amedeo, Aguzzi, Adriano · 2023 · Brain Pathology
  38. Intravascular injections of adenoassociated viral vector serotypes rh10 and PHP.B transduce murine sciatic nerve axons
    Hans E. Anderson, K Schaller, John H. Caldwell, Richard F ff Weir · 2019 · Neuroscience Letters
  39. Taking a Hint from Structural Biology: To Better Understand AAV Transport across the BBB
    Dan Wang, Guangping Gao · 2018 · Molecular Therapy
  40. Adeno-associated Virus-Mediated Gene Delivery Across the Blood-Brain Barrier
    Yizheng Yao, Fengfeng Bei · 2024 · Advances in neurobiology
  41. Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups
    Shingo Nakamura, Kazunori Morohoshi, Emi Inada, Yoko Sato, Satoshi Watanabe, Issei Saitoh, Masahiro Sato · 2023 · International Journal of Molecular Sciences
  42. Oligodendrocytes, the Forgotten Target of Gene Therapy
    Yasemin Ozgür-Gunes, Catherine Le Stunff, Pierre F Bougneres · 2024 · Cells
  43. Gene Therapy in the Nervous System: Failures and Successes
    Jayanth S. Chandran, Joseph M. Scarrott, Pamela J. Shaw, Mimoun Azzouz · 2017 · Advances in experimental medicine and biology
  44. Crossing the Blood-Brain Barrier with AAVs: What’s After SMA?
    Yujia A. Chan, Benjamin E. Deverman · 2022 · AAPS advances in the pharmaceutical sciences series
  45. Mosaic AAV mediates efficient transduction across the central and peripheral nervous systems
    Min Jiang, Wenqing Yin, Xiaolu Mo, Zhounan Wang, Mengsheng S. Qiu, Zhong‐Min Dai · 2025 · Molecular Brain
  46. From Treatment to Cure
    Ivan Pavlov, Stéphanie Schorge · 2014 · International review of neurobiology
  47. Viral Vectors in Primate Research: Examples from Parkinson’s Disease Research
    Grégory Porras, Benjamin Dehay, Erwan Bézard · 2013 · Neuromethods
  48. Induced Cell Turnover: A Novel Therapeutic Modality for In Situ Tissue Regeneration
    Francesco Albert Bosco Cortese, Sebastian P. Aguiar, Giovanni Santostasi · 2017 · Human Gene Therapy
  49. Viral Vector Gene Delivery to the Brain for Treating Neurogenetic Diseases
    Linnet Ramos, Jacqueline E. Hunter, John H N Wolfe · 2017 · Springer eBooks
  50. An Engineered Variant of the B1 Domain of Protein G Suppresses the Aggregation and Toxicity of Intra- and Extracellular Aβ42
    Victor Banerjee, Ofek Oren, Bar Dagan, Ran Taube, Stanislav Engel, Niv Papo · 2018 · ACS Chemical Neuroscience
  51. Modulating the Blood-Brain Barrier by Light Stimulation of Molecular-Targeted Nanoparticles
    Xiaoqing Li, Vamsidhara Vemireddy, Qi Cai, Hejian Xiong, Peiyuan Kang, Xiuying Li, Monica Giannotta, Heather N. Hayenga, Edward Pan, Shashank Ramesh Sirsi et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Gene therapy for Krabbe disease: evidence from mouse and canine models
    Yang Li, Xiang Dong, Jian Cheng Guo, Yafeng Lv · 2025 · Gene
  53. ADAR-mediated RNA editing in CNS disorders: from pathogenic mechanisms to therapeutic opportunities
    Fushuang Zheng, Rongli Guan, Xiaojin Yu, Jiaxin Yang, Hai Zhao, Fan Yang · 2026 · Cellular & Molecular Biology Letters
  54. CNS Gene Therapy Utilizing Intravenously Administered Viral Vectors
    Adam K. Bevan, Brian K. Kaspar · 2013 · AAPS advances in the pharmaceutical sciences series
  55. Bioluminescence-Based Monitoring of Virus Vector-Mediated Gene Transfer in Mice
    Casey A. Maguire · 2013 · Methods in molecular biology
  56. Gene Therapy of CNS Disorders Using Recombinant AAV Vectors
    Giridhar Murlidharan, Richard Jude Samulski, Aravind Asokan · 2016 · Springer eBooks
  57. Gene therapy approaches in central nervous system regenerative medicine
    Assumpció Bosch, Miguel Chillón · 2020 · Elsevier eBooks
  58. Huntingtin lowering therapeutics
    Neil Aronin M. D, Miguel Sena‐Esteves, Anastasia Khvorova, Marian DiFiglia, Michael Brodsky · 2024 · Elsevier eBooks
  59. Next generation AAV-F capsid gene therapy rescues disease pathology in a model of pyruvate dehydrogenase complex deficiency
    Anna Keegan, Özge Çetin, Ellie M. Chilcott, Juan F. Antinao Diaz, Simon D. Eaton, Simon N. Waddington, John Robert Counsell, Shamima Rahman, Rajvinder Karda · 2026 · Molecular Therapy Advances
  60. Highly EffectiveEx VivoGene Manipulation to Study Kidney Development Using Self-Complementary Adenoassociated Viruses
    Tielin Chen, Honglian Wang, Yun-Hong Liu, Yin Fang, Ruizhi Tan, Puhui Zhou, Qin Zhou, Xiaoyan Lv · 2014 · The Scientific World JOURNAL
  61. Systemic Gene Therapy for Targeting the CNS
    Sara E. Gombash, Kevin D. Foust · 2015 · Methods in molecular biology
  62. Gene Therapy for Neurodevelopmental Disorders
    Douglas M. McCarty, Haiyan Fu · 2014 · Encyclopedia of Life Sciences
  63. Development of Therapies for Spinal Muscular Atrophy Using Gene Therapy and Nanotechnology
    Daniel Little · 2013 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  64. MPS IIIA: gene therapy for brain and body
    Michael John Haas · 2013 · Science-Business eXchange
  65. Gene Therapy for Stroke
    Fanxia Shen, Hua Su · 2017 · Translational medicine research
  66. Gene Transfer in Spinal Muscular Atrophy
    Kevin D. Foust, Brian K. Kaspar · 2016 · Elsevier eBooks
  67. Biology of AAV Vectors in the Central Nervous System
    Giridhar Murlidharan · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  68. Virus-mediated Delivery of the Fmr1 Gene as a Tool for the Treatment of Fragile X Syndrome
    Shervin Gholizadeh Moghaddam · 2016 · TSpace (University of Toronto)
  69. Intravenously administered gene therapy for neuronopathic Gaucher disease
    Giulia Massaro · 2018 · UCL Discovery (University College London)
  70. Adeno-Associated Virus Vector Mediated Gene Delivery to Neurons and Glial Cells in Damaged Spinal Cord
    Victor L. Arvanian, Hayk A. Petrosyan · 2018 · Elsevier eBooks
  71. Intravenous injection of AAV-PHP.eB across the blood-brain barrier in the adult mouse for central nervous system gene therapy*
    Yongwei Shu, Jie Yao, Yang Qu, Jing Zheng, Jing Ding, Lina Zhang, Yefan Wang, Linlin Zhao, Jingyu Zhang, Siqi Tang · 2019 · Oncology and Translational Medicine
  72. DETERMINANTS OF AAV TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER
    Blake H. Albright · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  73. Introduction
    Magisetty Obulesu · 2020 · Elsevier eBooks
  74. Adeno-associated virus-mediated gene therapy in central nervous system genetic disorders
    Widler Casy, Qinglan Ling, Frances C. Shaffo, Sarah E. Sinnett, Steven James Gray · 2020 · Elsevier eBooks
  75. Minimally invasive routes of AAV administration to treat GM1 gangliosidosis
    Amanda L. Gross · 2020
  76. Seeking a Magic Bullet–the search for new Parkinson’s disease therapeutic agents
    James M. Gruschus · 2021 · Elsevier eBooks
  77. Faculty Opinions recommendation of Adeno-associated virus vector as a platform for gene therapy delivery.
    Michael George Fehlings · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  78. Can we prove the existence of God using quantitative biology ? Retracted
    Tidjani Locatelli · 2018 · Retracted
  79. Regulation des Autophagieproteins ULK1 im MPTP-Mausmodell des Morbus Parkinson
    Dirk Balke · 2022
  80. Viruses for Systemic Delivery
    Zikai Wang, Alon Greenbaum, Jennifer B. Treweek · 2023 · Neuromethods
  81. Noninvasive focused ultrasound-mediated delivery of rAAV9-EGFP vectors for neuronal targeting in rats
    Rui Wang, Jiayi Li · 2024 · NeuroImage
  82. Biodistribution Analysis of Adeno-Associated Viral Vectors of Serotypes 9 and rh.10 Encoding Arylsulfatase A Following Prior Immunization with Serotype 9 in Pigs
    Aysilu I. Mullagulova, A. A. Shaimardanova, Yana Olegovna Mukhamedshina, Valeriya V. Solovyeva, Ahmad Ibrahim, Albert Anatolyevich Rizvanov · 2024 · Učënye zapiski Kazanskogo universiteta. Seriâ Estestvennye nauki/Učënye zapiski Kazanskogo universiteta. Seriâ Estestvennye nauki/Učenye zapiski Kazanskogo gosudarstvennogo universiteta. Seriâ Estestvennye nauki
  83. Widespread Transduction of Mouse Neocortical Neurons by Subarachnoid Injection of AAV2
    Maria P. Smirnova, Aksiniya A. Osipova, Anastasia A. Borodinova, Tatyana M Bagrinovtseva, Yulia V. Dobryakova, Иван Васильевич Смирнов, Alexey Y. Malyshev · 2025 · Journal of Visualized Experiments
  84. Modification of the VP1u region boosts transduction of adeno-associated virus vectors for ocular gene therapy
    Mengtian Cui, Shun-Yun Cheng, Jialing Liang, Jackson McGowan, Meiyu Xu, Guangchao Xu, Li Luo, Joae Wu, Christine D. Harman, Amanda L. Jacobson et al. · 2026 · Molecular Therapy
  85. HML-2 env knockdown by AAV9-mediated miRNAs attenuates amyotrophic lateral sclerosis-like manifestations in mice
    Myoung-Hwa Lee, W. H. Li, Kevon Sampson, Stephanie H. Choi, Melina Jones, Joseph P. Steiner, Avindra Nath · 2026 · Brain
  86. Étude moléculaire de la propagation de l’agrégation de l’alpha-synucléine dans un modèle transgénique de la maladie de Parkinson : impact de la surexpression de la beta-synucléine à l’aide de vecteurs viraux adéno-associés (AAV)
    Dorian Sargent · 2018 · theses.fr (ABES)
  87. Compréhension de la neurophysiopathologie de l'ataxie de Friedreich et développement d'une approche de thérapie génique dans un nouveau modèle murin
    Charline de Montigny · 2018 · theses.fr (ABES)
  88. Thérapie génique pour l’amyotrophie spinale à l’aide de vecteur AAV
    Aurore Besse · 2019
  89. Development of safe and efficient aav vectors for retinal gene therapy
    Hanen Khabou · 2018 · theses.fr (ABES)
  90. Caractérisation de l’environnement thymique et de la thymopoïèse en conditions physiologiques et dans le contexte de stratégies thérapeutiques par ciblage direct du thymus
    Alice Machado · 2021
  91. Neurobiology of central defects and therapeutic exon skipping in a mouse model of Duchenne muscular dystrophy
    Amel Saoudi · 2023